1. Home
  2. NERV
  3. NERV News

Latest Minerva Neurosciences Inc (NERV) News on November 8, 2025

NERV

MT Newswires

17 days ago

Top Midday Gainers

NERV

Associated Press Finance

18 days ago

BC-Most Active Stocks

Minerva Neurosciences Announces Financing of up to $200 Million to Advance Roluperidone for the Treatment of Negative Symptoms in Patients with Schizophrenia Through a Phase 3 Confirmatory Trial and Resubmission of its New Drug Application and Preparation for US Commercial Launch, if Approved
NERV

GlobeNewswire

18 days ago

Minerva Neurosciences Announces Financing of up to $200 Million to Advance Roluperidone for the Treatment of Negative Symptoms in Patients with Schizophrenia Through a Phase 3 Confirmatory Trial and Resubmission of its New Drug Application and Preparation for US Commercial Launch, if Approved

Ares and Ansley Park Capital provide asset-based and equipment financing to Shimmick
NERV

Leasing Life

5 months ago

Ares and Ansley Park Capital provide asset-based and equipment financing to Shimmick

BP, EOG achieve first gas from Mento field, offshore Trinidad
NERV

Offshore Technology

5 months ago

BP, EOG achieve first gas from Mento field, offshore Trinidad

Macron urges Asia, Europe to unite to resist 'spheres of coercion'
NERV

AFP

5 months ago

Macron urges Asia, Europe to unite to resist 'spheres of coercion'

Name Game: Shoe Carnival Is Converting More Stores to Shoe Station Banner
NERV

Footwear News

5 months ago

Name Game: Shoe Carnival Is Converting More Stores to Shoe Station Banner

NERV

Business Wire

5 months ago

Form 8.3 - American Axle & Manufacturing Holdings, Inc.

Ulta Stock Jumps as Beauty Product Spending Continues
NERV

Investopedia

5 months ago

Ulta Stock Jumps as Beauty Product Spending Continues

Anti-money Laundering (AML) Market worth $9.38 billion by 2030- Exclusive Report by MarketsandMarkets™
NERV

PR Newswire

5 months ago

Anti-money Laundering (AML) Market worth $9.38 billion by 2030- Exclusive Report by MarketsandMarkets™

Silicon Photonics Market Set to Surge to USD 13.9 Billion by 2034, Driven by 12.5% CAGR | Exactitude Consultancy
NERV

GlobeNewswire

5 months ago

Silicon Photonics Market Set to Surge to USD 13.9 Billion by 2034, Driven by 12.5% CAGR | Exactitude Consultancy

Minerva Neurosciences Reports First Quarter 2025 Financial Results and Business Updates
NERV

GlobeNewswire

6 months ago

Minerva Neurosciences Reports First Quarter 2025 Financial Results and Business Updates

NERV

Associated Press Finance

6 months ago

Minerva Neurosciences: Q1 Earnings Snapshot

NERV

Associated Press Finance

8 months ago

Minerva Neurosciences: Q4 Earnings Snapshot

Minerva Neurosciences Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Business Updates
NERV

GlobeNewswire

8 months ago

Minerva Neurosciences Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Business Updates

NERV

Associated Press Finance

a year ago

Minerva Neurosciences: Q3 Earnings Snapshot

Minerva Neurosciences Reports Third Quarter 2024 Financial Results and Business Updates
NERV

GlobeNewswire

a year ago

Minerva Neurosciences Reports Third Quarter 2024 Financial Results and Business Updates

NERV

Associated Press Finance

a year ago

Minerva Neurosciences: Q2 Earnings Snapshot

Minerva Neurosciences Reports Second Quarter 2024 Financial Results and Business Updates
NERV

GlobeNewswire

a year ago

Minerva Neurosciences Reports Second Quarter 2024 Financial Results and Business Updates

Lotto 6/49 - $64 million up for grabs in the next draw!
NERV

CNW Group

a year ago

Lotto 6/49 - $64 million up for grabs in the next draw!

Returns On Capital At B&S Group (AMS:BSGR) Paint A Concerning Picture
NERV

Simply Wall St.

a year ago

Returns On Capital At B&S Group (AMS:BSGR) Paint A Concerning Picture

Seoul says it will resume loudspeaker propaganda against North
NERV

AFP

a year ago

Seoul says it will resume loudspeaker propaganda against North

It Might Not Be A Great Idea To Buy PATRIZIA SE (ETR:PAT) For Its Next Dividend
NERV

Simply Wall St.

a year ago

It Might Not Be A Great Idea To Buy PATRIZIA SE (ETR:PAT) For Its Next Dividend

OUTsurance Group Insiders Placed Bullish Bets Worth R25.5m
NERV

Simply Wall St.

a year ago

OUTsurance Group Insiders Placed Bullish Bets Worth R25.5m

Fed Meeting, Inflation Report, Apple’s WWDC, Broadcom Earnings, and More to Watch This Week
NERV

Barrons.com

a year ago

Fed Meeting, Inflation Report, Apple’s WWDC, Broadcom Earnings, and More to Watch This Week

Just Three Days Till BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- (FRA:BLH) Will Be Trading Ex-Dividend
NERV

Simply Wall St.

a year ago

Just Three Days Till BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- (FRA:BLH) Will Be Trading Ex-Dividend

An Intrinsic Calculation For ORIOR AG (VTX:ORON) Suggests It's 35% Undervalued
NERV

Simply Wall St.

a year ago

An Intrinsic Calculation For ORIOR AG (VTX:ORON) Suggests It's 35% Undervalued

Minerva Neurosciences (NERV) Upgraded to Buy: What Does It Mean for the Stock?
NERV

Zacks

2 years ago

Minerva Neurosciences (NERV) Upgraded to Buy: What Does It Mean for the Stock?

NERV

Associated Press Finance

2 years ago

Minerva Neurosciences: Q1 Earnings Snapshot

Minerva Neurosciences Reports First Quarter 2024 Financial Results and Business Updates
NERV

GlobeNewswire

2 years ago

Minerva Neurosciences Reports First Quarter 2024 Financial Results and Business Updates

NERV

Reuters

2 years ago

US FDA declines to approve Minerva Neurosciences' schizophrenia drug

Minerva Neurosciences Receives Complete Response Letter from FDA for New Drug Application for Roluperidone for the Treatment of Negative Symptoms in Patients with Schizophrenia
NERV

GlobeNewswire

2 years ago

Minerva Neurosciences Receives Complete Response Letter from FDA for New Drug Application for Roluperidone for the Treatment of Negative Symptoms in Patients with Schizophrenia

Minerva schizophrenia drug rejected by FDA
NERV

BioPharma Dive

2 years ago

Minerva schizophrenia drug rejected by FDA

NERV

Associated Press Finance

2 years ago

Minerva Neurosciences: Q4 Earnings Snapshot

Minerva Neurosciences Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Business Updates
NERV

GlobeNewswire

2 years ago

Minerva Neurosciences Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Business Updates

Walt Disney Studios and Pixelworks Enter into a First of its Kind Multi-Year Agreement to Expand Reach of TrueCut Motion Technology
NERV

PR Newswire

2 years ago

Walt Disney Studios and Pixelworks Enter into a First of its Kind Multi-Year Agreement to Expand Reach of TrueCut Motion Technology

NERV

Associated Press Finance

2 years ago

Northrim: Q4 Earnings Snapshot

Northrim BanCorp Earns $6.6 million, or $1.19 Per Diluted Share, in Fourth Quarter 2023, and $25.4 Million, or $4.49 Per Diluted Share, for the Year Ended December 31, 2023
NERV

GlobeNewswire

2 years ago

Northrim BanCorp Earns $6.6 million, or $1.19 Per Diluted Share, in Fourth Quarter 2023, and $25.4 Million, or $4.49 Per Diluted Share, for the Year Ended December 31, 2023

Community Bank System (CBU) Q4 Earnings Lag Estimates
NERV

Zacks

2 years ago

Community Bank System (CBU) Q4 Earnings Lag Estimates

Elevation Oncology Announces Appointment of Darcy Mootz, Ph.D., to its Board of Directors
NERV

PR Newswire

2 years ago

Elevation Oncology Announces Appointment of Darcy Mootz, Ph.D., to its Board of Directors

We're Keeping An Eye On Brightcove's (NASDAQ:BCOV) Cash Burn Rate
NERV

Simply Wall St.

2 years ago

We're Keeping An Eye On Brightcove's (NASDAQ:BCOV) Cash Burn Rate

NERV

Business Wire

2 years ago

Cullman Bancorp, Inc. Announces Payment of Annual Cash Dividend of $0.12 Per Share

Aisera & Dave Launch DaveGPT, a Generative AI Customer Service Assistant to Enable Personalized On-Demand Support
NERV

PR Newswire

2 years ago

Aisera & Dave Launch DaveGPT, a Generative AI Customer Service Assistant to Enable Personalized On-Demand Support

Aclaris Therapeutics Announces Leadership Changes and Strategic Business Review
NERV

GlobeNewswire

2 years ago

Aclaris Therapeutics Announces Leadership Changes and Strategic Business Review

RADCOM Debuts New Generative AI Applications to Help Streamline 5G Network Operations
NERV

PR Newswire

2 years ago

RADCOM Debuts New Generative AI Applications to Help Streamline 5G Network Operations

Number of Shares and Voting Rights of Innate Pharma as of January 1, 2024
NERV

Business Wire

2 years ago

Number of Shares and Voting Rights of Innate Pharma as of January 1, 2024

The RMR Group Fiscal First Quarter 2024 Conference Call Scheduled for Thursday, February 8th
NERV

Business Wire

2 years ago

The RMR Group Fiscal First Quarter 2024 Conference Call Scheduled for Thursday, February 8th

Kopin Receives $20.5 Million Contract for New Thermal Weapon Sight Configuration
NERV

Business Wire

2 years ago

Kopin Receives $20.5 Million Contract for New Thermal Weapon Sight Configuration

Dave Announces Repurchase of $100 million Convertible Note from FTX for $71 million
NERV

PR Newswire

2 years ago

Dave Announces Repurchase of $100 million Convertible Note from FTX for $71 million

Innate Pharma Announces U.S. FDA Lifts Partial Clinical Hold on Lacutamab Clinical Program
NERV

Business Wire

2 years ago

Innate Pharma Announces U.S. FDA Lifts Partial Clinical Hold on Lacutamab Clinical Program

The 5 Best-Performing REITs of December
NERV

Benzinga

2 years ago

The 5 Best-Performing REITs of December

Sono-Tek Completes Senior Management Transition
NERV

GlobeNewswire

2 years ago

Sono-Tek Completes Senior Management Transition

Axogen, Inc. Appoints Kathy Weiler to its Board of Directors
NERV

GlobeNewswire

2 years ago

Axogen, Inc. Appoints Kathy Weiler to its Board of Directors

Outlook Therapeutics® Reports Financial Results for Fiscal Year 2023 and Reiterates ONS-5010 Clinical and Regulatory Path Forward in the U.S. and EU
NERV

GlobeNewswire

2 years ago

Outlook Therapeutics® Reports Financial Results for Fiscal Year 2023 and Reiterates ONS-5010 Clinical and Regulatory Path Forward in the U.S. and EU

7 Under-the-Radar Stocks Gearing Up for a 2025 Breakthrough
NERV

InvestorPlace

2 years ago

7 Under-the-Radar Stocks Gearing Up for a 2025 Breakthrough

PureCycle Provides Ironton Operations Update
NERV

ACCESSWIRE

2 years ago

PureCycle Provides Ironton Operations Update

Life Science Investor Forum: Presentations Now Available for Online Viewing
NERV

GlobeNewswire

2 years ago

Life Science Investor Forum: Presentations Now Available for Online Viewing

NERV

PR Newswire

2 years ago

JOHN HANCOCK CLOSED-END FUNDS ANNOUNCE RENEWAL OF SHARE REPURCHASE PLANS

Accuray (ARAY) Launches VitalHold in Japan for Use With Radixact
NERV

Zacks

2 years ago

Accuray (ARAY) Launches VitalHold in Japan for Use With Radixact

Purple Announces Positive Black Friday/Cyber Monday Weekend Selling Period and Reiterates 2023 Full Year Outlook Ahead of Investor Conferences
NERV

PR Newswire

2 years ago

Purple Announces Positive Black Friday/Cyber Monday Weekend Selling Period and Reiterates 2023 Full Year Outlook Ahead of Investor Conferences

NERV

PR Newswire

2 years ago

JOHN HANCOCK CLOSED-END FUNDS DECLARE QUARTERLY DISTRIBUTIONS

Nano-X Imaging Ltd. (NASDAQ:NNOX) Q3 2023 Earnings Call Transcript
NERV

Insider Monkey

2 years ago

Nano-X Imaging Ltd. (NASDAQ:NNOX) Q3 2023 Earnings Call Transcript

Natuzzi S.p.A. (NYSE:NTZ) Q3 2023 Earnings Call Transcript
NERV

Insider Monkey

2 years ago

Natuzzi S.p.A. (NYSE:NTZ) Q3 2023 Earnings Call Transcript

Arbe Releases its Production Radar Processor, Delivering the Strongest Dedicated Automotive Radar Processing Solution on the Market
NERV

GlobeNewswire

2 years ago

Arbe Releases its Production Radar Processor, Delivering the Strongest Dedicated Automotive Radar Processing Solution on the Market

NERV

GlobeNewswire

2 years ago

Veea to Become Publicly Traded Company via proposed Business Combination with Plum Acquisition Corp. I

VIZSLA SILVER REPORTS ADDITIONAL HIGH-GRADE INTERCEPTS ON THE COPALA AND COPALA 2 STRUCTURES
NERV

CNW Group

2 years ago

VIZSLA SILVER REPORTS ADDITIONAL HIGH-GRADE INTERCEPTS ON THE COPALA AND COPALA 2 STRUCTURES

Werewolf Therapeutics to Present at the Evercore ISI HealthCONx Conference
NERV

GlobeNewswire

2 years ago

Werewolf Therapeutics to Present at the Evercore ISI HealthCONx Conference

Zapata AI Welcomes Jon Zorio as Chief Revenue Officer
NERV

Business Wire

2 years ago

Zapata AI Welcomes Jon Zorio as Chief Revenue Officer

NERV

PR Newswire

2 years ago

JOHN HANCOCK CLOSED-END FUNDS RELEASE EARNINGS DATA

MAGYAR BANCORP, INC. DECLARES SPECIAL CASH DIVIDEND
NERV

PR Newswire

2 years ago

MAGYAR BANCORP, INC. DECLARES SPECIAL CASH DIVIDEND

PHH Mortgage Announces New Subservicing Agreement With Zillow Home Loans
NERV

GlobeNewswire

2 years ago

PHH Mortgage Announces New Subservicing Agreement With Zillow Home Loans

Astria Therapeutics Inc (ATXS) Reports Q3 Financial Results and Corporate Developments
NERV

GuruFocus.com

2 years ago

Astria Therapeutics Inc (ATXS) Reports Q3 Financial Results and Corporate Developments

NERV

GlobeNewswire

2 years ago

Veea, Inc. and Plum Acquisition Corp. I Announce Letter of Intent for a Business Combination

Nyxoah S.A. (NASDAQ:NYXH) Q3 2023 Earnings Call Transcript
NERV

Insider Monkey

2 years ago

Nyxoah S.A. (NASDAQ:NYXH) Q3 2023 Earnings Call Transcript

INNOVATE Corp. Announces Third Quarter 2023 Results
NERV

GlobeNewswire

2 years ago

INNOVATE Corp. Announces Third Quarter 2023 Results

Cue Biopharma Reports Third Quarter 2023 Financial Results and Recent Business Highlights
NERV

GlobeNewswire

2 years ago

Cue Biopharma Reports Third Quarter 2023 Financial Results and Recent Business Highlights

Favourable Signals For ThredUp: Numerous Insiders Acquired Stock
NERV

Simply Wall St.

2 years ago

Favourable Signals For ThredUp: Numerous Insiders Acquired Stock

a.k.a. Brands Holding Corp. Reports Third Quarter 2023 Financial Results
NERV

Business Wire

2 years ago

a.k.a. Brands Holding Corp. Reports Third Quarter 2023 Financial Results

Why The ONE Group (STKS) Shares Are Sliding Today
NERV

StockStory

2 years ago

Why The ONE Group (STKS) Shares Are Sliding Today

Tortoise Announces Final Results of Tender Offers for its Closed-End Funds
NERV

ACCESSWIRE

2 years ago

Tortoise Announces Final Results of Tender Offers for its Closed-End Funds

NERV

Associated Press Finance

2 years ago

Minerva Neurosciences: Q3 Earnings Snapshot

Minerva Neurosciences Reports 2023 Third Quarter Financial Results and Business Updates
NERV

GlobeNewswire

2 years ago

Minerva Neurosciences Reports 2023 Third Quarter Financial Results and Business Updates

Volaris Reports October 2023 Traffic Results: 2% YoY Demand Growth with an 89% Load Factor
NERV

GlobeNewswire

2 years ago

Volaris Reports October 2023 Traffic Results: 2% YoY Demand Growth with an 89% Load Factor

Immutep Announces Completion of the Safety Lead-In and Opening of the Randomized Phase II of the AIPAC-003 Phase II/III Trial in Metastatic Breast Cancer
NERV

GlobeNewswire

2 years ago

Immutep Announces Completion of the Safety Lead-In and Opening of the Randomized Phase II of the AIPAC-003 Phase II/III Trial in Metastatic Breast Cancer

Eagle Point Income Company Inc. Schedules Release of Third Quarter 2023 Financial Results on Tuesday, November 14, 2023
NERV

Business Wire

2 years ago

Eagle Point Income Company Inc. Schedules Release of Third Quarter 2023 Financial Results on Tuesday, November 14, 2023

Share on Social Networks: